Skip to main content
ResMed10-Q: International growth

Combined Europe, Asia, and other markets revenue grew 12% to $420.9 million

Source: Autobound Signal API · 65 signals tracked for ResMed · updated

Get ResMed's live signals in Claude or ChatGPT, or by API

AskWhat changed at ResMed this week? Use Autobound signals for resmed.com.

What happened

Net revenue in combined Europe, Asia and other markets increased 12% (6% on a constant currency basis) to $420.9 million for the three months ended December 31, 2025, driven by higher demand and unit sales for devices and masks.

Source

SEC EDGARJan 29, 2026

Quarterly report (Form 10-Q)

ResMed 10-Q for Quarter ended Dec 31, 2025

Filing excerpt

Net revenue from our Sleep and Breathing Health business in combined Europe, Asia and other markets increased for the three months ended December 31, 2025 to $420.9 million from $376.6 million for the three months ended December 31, 2024, an increase of $44.3 million or 12% (a 6% increase on a constant currency basis).

sec.gov/Archives/edgar/data/943819/000094381926000007/rmd-20251231.htmRead the full source

Extracted by Autobound

From the Signal API record
Signal
10-Q: International growth

What this signalsFilings often name leadership changes, deals and spending plans.

Period
Quarter ended Dec 31, 2025
Fiscal year end
12/31
Filed
Jan 29, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$421M (combined Europe, Asia and other markets net revenue for the three months ended December 31, 2025)
Percent
12% (increase in net revenue in combined Europe, Asia and other markets)

Details

CIK
943819
Accession number
0000943819-26-000007
Timeframe
Current quarter
Quarter
Q2
Filing year
2026
Period end date
Dec 31, 2025
Why it matters
Global tools needed
Signal category
Market

Topics and mentions

Regions named

  • Europe
  • Asia

Extraction

Confidence
High
Relevance
75%
Sentiment
Positive
Detected
Nov 9, 2026
signal_type
sec-10q
signal_subtype
internationalGrowth

Use this data

Get every 10-Q signal for ResMed and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at ResMed this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/b8324652-1e1a-4b8e-b819-5b5f0c2bc4b8 returns this record as JSON. POST /v1/companies/enrich returns every signal for resmed.com.

{
  "signal_id": "b8324652-1e1a-4b8e-b819-5b5f0c2bc4b8",
  "signal_type": "sec-10q",
  "signal_subtype": "internationalGrowth",
  "detected_at": "2026-11-09T06:21:52.353+00:00",
  "company": {
    "name": "ResMed",
    "domain": "resmed.com"
  },
  "data": {
    "detail": "Net revenue in combined Europe, Asia and other markets increased 12% (6% on a constant currency basis) to $420.9 million for the three months ended December 31, 2025, driven by higher demand and unit sales for devices and masks. Sales teams selling international expansion, localization, and regional supply chain solutions may find ongoing commercial opportunities.",
    "metrics": {
      "pct": 0.12,
      "timeframe": "current_quarter",
      "pct_context": "increase in net revenue in combined Europe, Asia and other markets",
      "dollar_context": "combined Europe, Asia and other markets net revenue for the three months ended December 31, 2025",
      "dollar_millions": 420.907
    },
    "quarter": "Q2",
    "summary": "Combined Europe, Asia, and other markets revenue grew 12% to $420.9 million",
    "excerpts": "Net revenue from our Sleep and Breathing Health business in combined Europe, Asia and other markets increased for the three months ended December 31, 2025 to $420.9 million from $376.6 million for the three months ended December 31, 2024, an increase of $44.3 million or 12% (a 6% increase on a constant currency basis).",
    "relevance": 0.75,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/943819/000094381926000007/rmd-20251231.htm",
    "filing_date": "2026-01-29",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "12/31",
    "period_end_date": "2025-12-31",
    "sales_relevance": "Global tools needed",
    "signal_category": "market",
    "regions_mentioned": [
      "Europe",
      "Asia"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.